Building Scalable Non-Viral Gene-Edited Cell Therapy Processes

Join this webinar to learn how leading cell therapy developers are tackling one of the field’s biggest challenges: scaling non-viral gene-edited cell therapies from research to manufacturing. Through real-world data in T, NK, and CD34+ cells, experts will demonstrate how electroporation can enable efficient CRISPR knock-out, knock-in, and transposon-based editing while preserving critical cell quality attributes. You’ll gain practical insights into optimizing gene delivery, improving process consistency, and building scalable, GMP-ready workflows that support successful clinical and commercial development.